Andere Sprachen Agios Pharmaceuticals, Inc.

Aktien

A1W2RM

US00847X1046

AGIO

Realtime-Estimate Cboe BZX Andere Börsenplätze 21:57:42 02.05.2024			% 5 Tage	% 1. Jan.
34.48 ^USD	+2.42%		+9.84%	+56.20%

19:03	Agios Pharmaceuticals-Aktien steigen nach geringerem Q1-Verlust	MT
13:01	Agios Pharmaceuticals, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss	19:03
Agios Pharmaceuticals : First Quarter 2024 Financial Results Presentation	15:58
Agios Pharmaceuticals: Q1 Earnings Snapshot	13:30
Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q1 Revenue $8.2M	13:14
Agios Reports Business Highlights and First Quarter 2024 Financial Results	13:02
Agios Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13:01
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024	18.04.
Agios Publishes 2024 Environmental, Social and Governance Report	10.04.
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report	09.04.
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	06.03.
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	05.03.
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024	22.02.
Agios Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15.02.
Agios Pharmaceuticals 2023 Loss Widens, Revenue Rises	15.02.
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	15.02.
Agios Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15.02.
Servier replonge dans le rouge en raison du dossier Mediator	07.02.
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024	02.02.
Agios Pharmaceuticals Insider Sold Shares Worth $277,397, According to a Recent SEC Filing	09.01.
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio	08.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Agios Pharmaceuticals, Inc.

Aktien

A1W2RM

US00847X1046

AGIO

Andere Sprachen

Filter